PMC:7033706 / 6147-6793
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 163 | 451-452 | Gene | denotes | S | Gene:43740568 |
| 164 | 433-434 | Gene | denotes | S | Gene:43740568 |
| 165 | 12-20 | Species | denotes | SARS-CoV | Tax:694009 |
| 166 | 25-33 | Species | denotes | MERS-CoV | Tax:1335626 |
| 167 | 176-184 | Species | denotes | SARS-CoV | Tax:694009 |
| 168 | 281-289 | Species | denotes | MERS-CoV | Tax:1335626 |
| 169 | 423-432 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 170 | 466-477 | Species | denotes | coronavirus | Tax:11118 |
| 171 | 508-517 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 172 | 572-583 | Species | denotes | coronavirus | Tax:11118 |
| 173 | 590-599 | Species | denotes | 2019-nCoV | Tax:2697049 |
| 174 | 189-208 | Disease | denotes | MERS-CoV infections | MESH:D018352 |
| 175 | 388-401 | Disease | denotes | CoV infection | MESH:D018352 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T20 | 248-255 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T21 | 296-306 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T26 | 12-20 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T27 | 176-184 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T28 | 198-208 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T29 | 392-401 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T87 | 296-315 | http://purl.obolibrary.org/obo/CHEBI_33708 | denotes | amino acid residues |
| T88 | 296-315 | http://purl.obolibrary.org/obo/PR_000036907 | denotes | amino acid residues |
| T89 | 564-566 | http://purl.obolibrary.org/obo/CLO_0050050 | denotes | S1 |
| T90 | 570-571 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T46 | 248-255 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T47 | 296-306 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
| T48 | 296-301 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
| T49 | 302-306 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T34 | 0-264 | Sentence | denotes | The RBDs of SARS-CoV and MERS-CoV contain multiple conformation-dependent neutralizing epitopes that induce more potent neutralizing antibodies and protective efficacy against SARS-CoV and MERS-CoV infections, respectively, than other regions in S protein [5,8,9]. |
| T35 | 265-527 | Sentence | denotes | Modification of MERS-CoV S-RBD amino acid residues based on the structure design could improve its protection against MERS-CoV infection [9], suggesting that 2019-nCoV S-RBD or modified S-RBD of other coronavirus may be applied for developing 2019-nCoV vaccines. |
| T36 | 528-646 | Sentence | denotes | Of course, the RBD-containing S and S1 of a coronavirus, e.g. 2019-nCoV, can also be used for vaccine development [8]. |